The policy discloses that Noom uses user data for research studies and publication, states that published research uses only aggregated, de-identified data, and provides an opt-out form for users who do not wish their data to be used in research.
This analysis describes what Noom's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision discloses a research use of user data, including the sensitive categories collected, and references an Advarra Institutional Review Board informed consent document, indicating that some research activities may be subject to IRB oversight. The opt-out is available but requires affirmative user action through a separate form.
Interpretive note: Whether Noom's research activities constitute human subjects research subject to the Common Rule or HIPAA research provisions depends on the nature of the research, institutional affiliations, and funding sources, which are not specified in the policy.
Under this provision, user data may be used in Noom's research studies, with the policy stating that publications use only aggregated, de-identified data. Users who do not wish their information to be used in research studies may opt out by completing the research opt-out form linked in the policy. The reference to an Advarra IRB informed consent document suggests some research activities operate under formal research ethics oversight.
Cross-platform context
See how other platforms handle Research Participation and Opt-Out and similar clauses.
Compare across platforms →"We are committed to validating our approach to lifelong behavior change using science. We publish using only aggregated, de-identified data. If you would not like your information used in our studies, please fill out the opt out of Noom research form.Excerpt from Noom's Privacy Policy
(1) REGULATORY LANDSCAPE: Research use of health data by a consumer technology platform engages FDA Common Rule considerations if research meets the definition of human subjects research; IRB oversight is referenced in the policy through …
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision discloses a research use of user data, including the sensitive categories collected, and references an Advarra Institutional Review Board informed consent document, indicating that some research activities may be subject to IRB oversight. The opt-out is available but requires affirmative user action through a separate form.
Under this provision, user data may be used in Noom's research studies, with the policy stating that publications use only aggregated, de-identified data. Users who do not wish their information to be used in research studies may opt out by completing the research opt-out form linked in the policy. The reference to an Advarra IRB informed consent document suggests some …
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Noom.